PROFESSIONAL EDITION

The largest community of pharma leaders

Subscribe to Our News!

Natalie Yeadon

Featured Authors

2020: looking back at the year when everything changed

A version of this article was previously published on Pharmaphorum. I think it’s fair to say that 2020 will not be particularly missed by anyone....
Natalie Yeadon - 0
Read more
Featured Authors

Top 10 Tips for Creating Company Culture in a Virtual World

For many companies, the transition from in-office to remote or flexible work at the beginning of the pandemic may have started off a bit...
Natalie Yeadon - 0
Read more
Natalie Yeadon

Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal

A version of this article was previously published on Pharmaphorum. There is not a single industry that has been left untouched by COVID-19. While the...
Natalie Yeadon - 0
Read more
Natalie Yeadon

Secondary effects of COVID-19 on the healthcare system and patients

A version of this article was previously published on Pharmaphorum. By now, your social media feeds are probably full of COVID-19-related news articles, opinion...
Natalie Yeadon - 0
Read more
Natalie Yeadon

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in Pharma when it comes to...
Natalie Yeadon - 0
Read more
Natalie Yeadon

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is “fake news.” We hear it...
Natalie Yeadon - 0
Read more
123...5Page 1 of 5

Recent Articles

Exicure Granted Orphan Drug Designation by the U.S. Food and Drug Administration for Cavrotolimod

Industry News

AavantiBio Adds Veteran Life Sciences Executive Douglas J. Swirsky as Chief Financial Officer and Treasurer

Look Who’s On the Move!

Xentria Announces Submission of an Investigational New Drug (IND) Application for XTMAB-16 in the Treatment of Sarcoidosis

Regulatory Affairs

Quantum Materials Corp Expands Executive Leadership Team To Execute Growth Strategy

Look Who’s On the Move!

Repertoire Immune Medicines Pre-publishes New Research Identifying Potential Mechanisms for Immune Escape of SARS-CoV-2 Variants to Support Novel Approaches for T Cell Based Therapeutic...

Industry News

Altasciences Conducts Phase I Study in Healthy Normal Subjects for RLS-0071 for Treatment of Acute Lung Injury Due to COVID-19 Pneumonia

Clinical Trials

QIAGEN Launches QIAsphere Cloud-Based Connectivity Solution to Enhance QIAstat-Dx Capabilities in Digital Diagnostics

Industry News

Axcella Announces Alison D. Schecter, M.D., as President of R&D

Look Who’s On the Move!

U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer

Editor´s Pick

Oregon Bioscience Association Appoints 2021 Leadership

Look Who’s On the Move!

Merck Provides Update on KEYTRUDA® (pembrolizumab) Indication in Metastatic Small Cell Lung Cancer in the US

Industry News

Glaukos Appoints Denice Torres and Dr. Leana Wen to its Board of Directors

Look Who’s On the Move!

Yicai: WHO Says Rich Countries Should Fulfill Their Promise of Providing Vaccines Fairly

Editor´s Pick

Shorla Pharma Announces U.S. Industry Veteran Nicholas Holsman as Chief Commercial Officer

Industry News

Iktos Announces Collaboration With Pfizer in AI for Drug Design

Editor´s Pick

2020 © Copyright - TPMG